Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Fludrocortisone in Septic Shock
NCT02069288Phase 3Withdrawn
- Sponsor
- CHU Rennes
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fludrocortisone in septic shock, sponsored by CHU Rennes. Status: withdrawn.
02
Drugs
fludrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02069288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02069288.